个人简历

丁娅，女，教授，博士生导师。教育部“新世纪优秀人才”（2010），江苏省“青蓝工程”优秀青年骨干教师（2010），江苏省第五期“333高层次人才培养工程”培养对象（2016）。从事纳米药物分析和药物光谱分析相关研究，在纳米科技和药物材料研究方面的国际著名学术期刊：Biomaterials, ACS Appl. Mat. Interfaces, Mol Ther, Chem Eur J, J Mater Chem, J Phys Chem C等发表论文40余篇，拥有专利4项。获高等学校科学研究优秀成果奖，自然科学奖，一等奖1项（2011）。《有机光谱分析》教材编委，人民卫生出版社（2009）。Biomaterials, Bioconjgate Chem, Theranostics, Polym Chem, Mol Pharm等期刊的审稿人。作为负责人主持国家自然科学基金项目2项，中国博士后基金2项，省部级基金项目5项。《药学学报》青年编委，中国化学会会员，美国化学会会员，中美纳米医学与纳米生物技术学会（CASNN）终身会员，中国微米纳米技术学会高级会员。
教育和工作经历
2017 - 迄今， 中国药科大学，教授
2015 - 2017年，中国药科大学，特聘研究员
2013 - 2014年，University of Massachusetts-Amherst，化学系，访问学者
2008 - 2012年，南京大学，生命科学学院，生物学博士后
2007 - 2015年，中国药科大学，讲师、副教授
2004 - 2007年，南京大学，化学化工学院，分析化学博士
2001 - 2004年，中国药科大学，药物化学硕士
1995 - 1999年，中国药科大学，化学制药学士

研究领域

药物分析新材料和新技术；疾病诊断探针；光谱技术在药物分析中的应用

近期论文

1.Y. Ju, H. Zhang, J. Yu*, S. Tong, N. Tian, Z. Wang, X. Wang, X. Su, X. Chu, J. Lin, Y. Ding, G. Li, F. Sheng*, Y. Hou*, Monodisperse Au-Fe2C Janus Nanoparticles: an Attractive Multifunctional Material for Triple-Modal Imaging-Guided Tumor Photothermal Therapy. ACS Nano2017, pub online. DOI: 10.1021/acsnano.7b04461 (SCI IF=13.942)
2.Y.-Y. Gao†, H. Chen†, Y.-Y. Zhou, L.-T. Wang, Y. Hou*, X.-H. Xia, Y. Ding*, Intraorgan Targeting of Gold Conjugates for Precise Liver Cancer Treatment. ACS Applied Materials & Interfaces2017, pub online. DOI: 10.1021/acsami.7b08969 (SCI IF=7.145)
3.J. Hong, Y.-F. Chen, J.-J. Shen, Y. Ding*, Noninvasive Detection and Imaging of Matrix Metalloproteinases for Cancer Diagnosis. Journal of Analysis and Testing2017, pub online. DOI: 10.1007/s41664-017-0036-2. (SCI IF=N/A)
4.T. Cui†, J.-J. Liang†, H. Chen, D.-D. Geng, L. Jiao, J.-Y. Yang, H. Q., C. Zhang*, Y. Ding*, The performance of Doxorubicin-conjugated gold nanoparticles: Regulation of drug location. ACS Appl. Mater. Interf.2017, 2017, 9, 8569–8580. (SCI IF=7.145)
5.H.-S. Wang, J. Li, J.-Y. Li, K. Wang, Y. Ding, X.-H. Xia*, Lanthanide-based metal-organic framework nanosheets with unique fluorescence quenching properties for two-color intracellular adenosine imaging in living cells. NPG Asia Mater.2017, 9, e354. (SCI IF=8.772)
6.D.-Y. Wu†, Y. Ma†, X.-S. Hou, P. Wang, H. Chen, C. Zhang, Y. Ding*, Co-delivery of antineoplastic and protein drugs by chitosan nanocapsules for a collaborative tumor treatment. Carbohydr. Polym.2017, 157, 1470–1478. (SCI IF=4.219)
7.Q.-Y. Bao, A.-Y. Liu, Y. Ma, H. Chen, J. Hong, W.-B. Shen, C. Zhang, Y. Ding*, The effect of oil-water partition coefficient on the distribution and cellular uptake of liposome-encapsulated gold nanoparticles. Colloid. Surf. B2016, 146, 475–481. (SCI IF=3.902)
8.Y.-F. Chen†, J. Hong†, D.-Y. Wu, Y.-Y. Zhou, M. D’Ortenzio, Y. Ding*, Xing-Hua Xia, In vivo mapping and assay of matrix metalloproteases for the liver tumor diagnosis. RSC Adv.2016, 6, 8336–8345. (SCI IF=3.289)
9.N. Zhang†, H. Chen†, A.-Y. Liu, J.-J. Shen, V. Shah, C. Zhang, J. Hong, Y. Ding*, Gold conjugate-based liposomes with hybrid Cluster Bomb structure for liver cancer therapy. Biomaterials2016, 74, 280–291. (SCI IF=8.387)
10.F.-F. Zhang, Y.-Q. Zhao, J.-P. Fan, L.-G. Liu, R.-W. Li, W.-B. Shen*, Y. Ding*, Structural identification of 4-benzyl-voglibose hydrochloride monohydrate via NMR and single-crystal X-ray diffraction methods. Carbohydr. Res.2015, 402, 81–86. (SCI IF=1.966)
11.F.-F. Zhang, M.-H. Jiang, L.-L. Sun, F. Zheng, L. Dong, V. Shah, W.-B. Shen*, Y. Ding*, Quantitative analysis of Sitagliptin using 19F-NMR method: A universal technique for fluorinated compounds detection. Analyst2015, 140, 280–286. (SCI IF=3.906)
12.J.-J. Liang, Y.-Y. Zhou, J. Wu, Y. Ding*, Gold nanoparticle-based drug delivery platform for antineoplastic chemotherapy. Curr. Drug Met.2014, 15, 620–631. (SCI IF=3.487)
13.Y. Ding†, Z. Jiang†, K. Saha, C. S. Kim, S. T. Kim, R. F. Landis, V. Rotello*, Gold nanoparticles for nucleic acid delivery. Mol. Ther.2014, 22, 1075–1083. (SCI IF=6.425, 高引用论文)
14.Y. Ding, J.-J. Liang, Z.-Y. Liu, D. Wu, L. Dong, X.-H. Xia*, W.-B. Shen, Can Zhang*, Development of a liver-targeting gold-PEG-galactose nanoparticle platform and the structure-function study. Part. Part. Syst. Charact.2014, 31, 347–356. (SCI IF=3.85)
15.Y. Ding*, Y.-Y. Zhou, H. Chen, D.-D. Geng, D.-Y. Wu, J. Hong, W.-B. Shen, T.-J. Hang, C. Zhang, The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles. Biomaterials2013, 34, 10217–10227. (SCI IF 8.312)
16.Q.-Y. Bao, D.-D. Geng, J.-W. Xue, G. Zhou, S.-Y. Gu, Y. Ding*, C. Zhang*, Glutathione-mediated drug release from Tiopronin-conjugated gold nanoparticles for acute liver injury therapy. Inter. J. Pharm.2013, 446, 112–118. (SCI IF=3.789)
17.Y. Ding, P. Zhang, X.-Y. Tang, C. Zhang*, S. Ding, H. Ye, Q.-L. Ding, W.-B. Shen, Q.-N. Ping, PEG prodrug of gambogic acid: Amino acid and dipeptide spacer effects. Polymer2012, 53, 1694–1702. (SCI IF=3.766)
18.Y. Ding, B. Jin, G. Gu, X.-H. Xia*, One-step pyrolysis method for the synthesis of highly efficient 3D hollow carbon nanostructures supported catalysts. J. Mater. Chem.2009, 19, 1941–1946. (SCI IF=5.968)
19.Y. Ding, G. Gu, X.-H. Xia*, Cysteine-grafted chitosan mediated gold fabrication: From nanochains to microcubes. J. Mater. Chem.2009, 19, 795–799. (SCI IF=5.968)
20.Y. Ding, Y.-L. Hu, G. Gu, X.-H. Xia*, Controllable synthesis and formation mechanism investigation of Prussian blue nanocrystals by using polysaccharide hydrolysis method. J. Phys. Chem. C2009, 113, 14838–14843. (SCI IF=4.835)